GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling (Q40410872)
Jump to navigation
Jump to search
scientific article published on 14 December 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling |
scientific article published on 14 December 2016 |
Statements
1 reference
GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling (English)
1 reference
Corinna Koch
Bardia Samareh
Perihan Mir
Lothar Kanz
Cornelia Zeidler
14 December 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference